e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Improved understanding of the basic mechanisms impact on the management of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Phosphodiesterase expression and activity in human airways
R. A. Clayton, A. Mackenzie, C. A. J. Dick, S. F. Hastings, A. Cooreman, V. Anikin, S. J. MacKenzie (Glasgow, Bradford, United Kingdom)
Source:
Annual Congress 2004 - Improved understanding of the basic mechanisms impact on the management of COPD
Session:
Improved understanding of the basic mechanisms impact on the management of COPD
Session type:
Oral Presentation
Number:
266
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. A. Clayton, A. Mackenzie, C. A. J. Dick, S. F. Hastings, A. Cooreman, V. Anikin, S. J. MacKenzie (Glasgow, Bradford, United Kingdom). Phosphodiesterase expression and activity in human airways. Eur Respir J 2004; 24: Suppl. 48, 266
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
PDE isozymes and effects of selective PDE inhibitors on human lung fibroblasts (Fbs)
Source: Eur Respir J 2005; 26: Suppl. 49, 551s
Year: 2005
Effects of PDE4 inhibitors on eotaxin-3 (CCL26) expression in lung epithelial cells
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009
The PDE4 inhibitor roflumilast N-oxide partly reversed TGFß1-induced changes in collagen I and E-cadherin expression in human airway epithelial cells
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD
Year: 2008
TGF-β modulates Na
+
,K
+
-ATPase expression and activity in the lung epithelium
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008
Inhibition of phosphodiesterase 4B enhances glucocorticoid-dependent gene transcription in human airway epithelial cells: Implications for the treatment of COPD
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Upregulation of smooth muscle Rho-kinase protein expression in human asthma
Source: Eur Respir J, 55 (3) 1901785; 10.1183/13993003.01785-2019
Year: 2020
Characterisation of eppin function: expression and activity in the lung
Source: Eur Respir J, 50 (1) 1601937; 10.1183/13993003.01937-2016
Year: 2017
MAP kinase phosphatase 1 mediates glucocorticoid inhibition of CD38 expression in human airway smooth muscle
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008
Phosphodiesterase 4 and 5 inhibitors decrease HO-1 and IL-8 gene expression induced by cigarette smoke
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008
The novel phosphodiesterase 4 inhibitor CI-1044 inhibits
in vitro
LPS-induced TNFα production in whole blood of COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 34s
Year: 2001
IL-13 induces glucocorticoid resistance in iNOS expression and activity in human airway epithelial cells (HAECs)
Source: International Congress 2017 – New insights into pathogenesis of lung disease
Year: 2017
The combination of PDE4 and PDE5 inhibitors reduces YAP expression in IPF
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017
Effects of phosphodiesterase-4 inhibitors on surfactant protein-A expression in adult alveolar epithelial cells type II
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007
Metformin regulates sirtuin expression in airway epithelial cells
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018
Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury
Source: Eur Respir J 2003; 22: 20-27
Year: 2003
LSC 2010 Abstract: Experimental asthma: expression and activation of protein kinase C isoenzymes in airway smooth muscles (ASM) & lymphocytes and structural changes in lung tissues during the development of airway hypersensitivity in guinea pig model of asthma
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
PP216 – Glucocorticoids exacerbate TGFß1 mediated fibrotic signalling in lung fibroblasts by inhibition of metalloproteinase expression and activity
Source: ERS Lung Science Conference 2021
Year: 2021
Anti-inflammatory effect of bosentan on endothelin-1- and TNF-α-induced GMCSF expression in human airways smooth muscle cells – role of MAPkinases ERK-1,-2
Source: Annual Congress 2007 - Inflammatory cell biology
Year: 2007
Effects of pendrin inhibitor (PDI_C01) in vitro, and in vivo models of lipopolysaccharide-induced airway inflammation.
Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Year: 2019
Gene transfer of a β-adrenergic receptor kinase inhibitor up-regulated levels of β-adrenergic receptor and cAMP in asthmatic murine lung
Source: Eur Respir J 2005; 26: Suppl. 49, 580s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept